Enterovirus infections: A review of clinical presentation, diagnosis, and treatment

Dermatologic Clinics

Volumn 20, Issue 2, 2002, Pages 217-223

  Stalkup, Jennifer R ^b   Chilukuri, Suneel ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b 7675 Phoenix Apt 615 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PLECONARIL;

CLINICAL FEATURE; COXSACKIE VIRUS; ECHO VIRUS; ENCEPHALITIS; ENTEROVIRUS; ENTEROVIRUS INFECTION; MENINGITIS; NEWBORN SEPSIS; PATHOGENESIS; PICORNAVIRUS; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEASONAL VARIATION; UNITED STATES; VACCINATION; VIRUS MYOCARDITIS; HUMAN;

ENTEROVIRUS INFECTIONS; HUMAN; HUMANS;

EID: 0035986487     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(01)00009-2     Document Type: Review

References (54)

1. Enteroviruses and meningitis
2. Picornavirus infections: A primer for the practitioner
3. Enterovirus infections in neonates
4. Current status of poliovirus infections
5. Enteroviral infections of the central nervous system
6. Enterovirus infections: Diagnosis and treatment
7. Enteroviruses and myocarditis
8. The Seattle virus watch: II. Objectives, study population and its observation, data processing and summary of illnesses
9. Clinical and economic impact of enterovirus illness in private pediatric practice
10. The virus watch program: A continuing surveillance of viral infections in metropolitan New York familites: II. Laboratory methods and preliminary report on infections revealed by virus isolation
11. Nonpolio enteroviruses and the febrile young infant: Epidemiologic, clinical and diagnositic aspects
12. Picomavirus pathogenesis: Viral access, attachement, and entry into susceptible cells
13. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM: A population based case-control study
14. Occurrence of enteroviruses in community swimming pools
15. Molecular detection and typing of human picornaviruses
16. Poliomyelitis eradication
17. Minireview: Eradication of polio by vaccination
18. Commentary: The unfolding story of global poliomyelitis eradication
19. Group B coxsackievirus infections in infants younger than three months of age: A serious childhood illness
20. Association of clinical presentation, laboratory findings, and virus serotypes with the presence of meningitis in hospitalized infants with enterovirus infection
21. Neonatal enterovirus infection: Virology, serology, and effects of intravenous immune globulin
22. Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970-1983
23. Activity of pleconaril against enterovirses
24. Enteroviruses in human disease
25. Management of central nervous system infections during an epidemic of enteroviral aseptic meningitis
26. Enteroviruses: Poliovirus (poliomyelitis), coxsackieviruses, echoviruses, and enteroviruses
27. Zoster-like eruption due to echovirus 6
28. Hand, foot, and mouth disease
29. An epidemic of enterovirus 71 infection in Taiwan
30. Myocarditis possibly due to coxsackie group A, type 16, virus
31. Fatal infection in an infant associated with coxsackievirus group A, type 16
32. Herpangina: Clinical studies of a specific infectious disease
33. A study of the neurological disorder associated with acute hemorrhagic conjunctivitis due to entervirus 70
34. Meningitis and encephalitis
35. Enteroviral meningitis in infancy: Potential role for polymerase chain reaction in patient management
36. Aseptic meningitis among infants less than two years of age: Acute illness and neurologic complications
37. Outcome in children with enteroviral meningitis during the first year of life
38. Diseases that mimic herpes simplex encephalitis: Diagnosis, presentation, and outcome
39. Molecular detection and differentiation of enteroviruses in endomyocaridal biopsies and pericardial effusions from dilated cardiomyopathy and myocarditis
40. Detection of enterovirus-specific RNA sequences in explanted myocardium biopsy specimens from patients with dilated ischemic cardiomyopathy
41. Detection of enteroviral RNA in endstage dilated cardiomyopathy in children and adolescents
42. Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system
43. Diagnosis of enterovirus infection by polymerase chain reaction of multiple specimen types
44. The role of enteroviral infections in the development of IDDM: Limitations of current approaches
45. Clinical utility of polymerase chain reaction testing for enteroviral meningitis
46. Potential cost savings through rapid diagnosis of enteroviral meningitis
47. Estimating the economic impact of viral meningitis in the United States
48. Impact of reverse-transcription-polymerase chain reaction diagnosis of enterovirus infections on the care of febrile children
49. Diagnosis of enteroviral central nervous system infection by polymerase chain reaction during a large community outbreak
50. Use of the polymerase chain reaction for diagnosis of picomavirus infection in subjects with and without respiratory symptoms
51. Antiviral therapy for enteroviral infections
52. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients
53. Oral pleconaril reduces the duration and severity of enteroviral meningitis in children
54. Oral efficacy of VP 63843 in coxsackievirus A21 infected volunteers